AC Immune SA (ACIU) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 to invest. The stock shows no significant positive catalysts, weak financial performance, and neutral trading sentiment. While technical indicators are mildly positive, the lack of strong growth prospects and negative financial trends suggest holding off on investment for now.
The MACD is positive but contracting, RSI is neutral at 47.016, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 3.085, R1: 3.406, S1: 2.764, R2: 3.604, S2: 2.566. The stock has a 60% chance to move -1.05% in the next week and -13.91% in the next month, indicating a bearish short-term outlook.

NULL identified. No recent news or significant insider/hedge fund activity.
The stock also has a bearish short-term trend based on candlestick analysis.
In 2025/Q4, revenue dropped significantly to 338,000 (-70.27% YoY), net income fell to -14,373,000 (-9.01% YoY), and EPS declined to -0.14 (-12.50% YoY). Gross margin remained stable at 100%.
No recent analyst ratings or price target changes available.
